ASK 1-dependent endothelial cell activation is critical in ovarian cancer growth and metastasis
暂无分享,去创建一个
Ming-zhu Yin | Xia Li | W. Min | Haifeng Zhang | W. Ji | Yong-hao Li | D. Breckenridge | H. Zhou | Hongmei Li | Jiqin Zhang | Caixia Lin | Mingzhu Yin
[1] Wang Min,et al. Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer. , 2016, The Journal of clinical investigation.
[2] J. McGee,et al. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids. , 2016, Endocrine-related cancer.
[3] A. Sugimoto,et al. Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids , 2015, Oncotarget.
[4] R. Drapkin,et al. Combined therapy with thrombospondin‐1 type I repeats (3TSR) and chemotherapy induces regression and significandy improves survival in a preclinical model of advanced stage epithelial ovarian cancer , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] W. Min,et al. Thioredoxin-2 Inhibits Mitochondrial Reactive Oxygen Species Generation and Apoptosis Stress Kinase-1 Activity to Maintain Cardiac Function , 2015, Circulation.
[6] Wang Min,et al. Carbamoylating Activity Associated with the Activation of the Antitumor Agent Laromustine Inhibits Angiogenesis by Inducing ASK1-Dependent Endothelial Cell Death , 2014, PloS one.
[7] Will Liao,et al. The cellular and molecular origin of tumor-associated macrophages , 2014, Science.
[8] W. Min,et al. SOCS1 prevents graft arteriosclerosis by preserving endothelial cell function. , 2014, Journal of the American College of Cardiology.
[9] G. Freeman,et al. Therapeutic PD-1 pathway blockade augments with other modalities of immunotherapy T-cell function to prevent immune decline in ovarian cancer. , 2013, Cancer research.
[10] Christina S. Leslie,et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression , 2013, Nature Medicine.
[11] G. Coukos,et al. Deciphering and reversing tumor immune suppression. , 2013, Immunity.
[12] C. Lewis,et al. Macrophage regulation of tumor responses to anticancer therapies. , 2013, Cancer cell.
[13] S. Kutschera,et al. VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd , 2012, The Journal of experimental medicine.
[14] Karin Jirström,et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. , 2011, Cancer discovery.
[15] P. Carmeliet,et al. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. , 2011, Cancer cell.
[16] R. Jain,et al. Polarization of tumor-associated macrophages: a novel strategy for vascular normalization and antitumor immunity. , 2011, Cancer cell.
[17] J. Au,et al. Intraperitoneal therapy for peritoneal cancer. , 2010, Future oncology.
[18] Jeffrey W. Pollard,et al. Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.
[19] Steven J. M. Jones,et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. , 2010, The New England journal of medicine.
[20] W. Min,et al. JAK2 and SHP2 Reciprocally Regulate Tyrosine Phosphorylation and Stability of Proapoptotic Protein ASK1* , 2009, Journal of Biological Chemistry.
[21] Hiromi Nakamura,et al. ASK1 and ASK2 differentially regulate the counteracting roles of apoptosis and inflammation in tumorigenesis , 2009, The EMBO journal.
[22] Elisabetta Dejana,et al. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. , 2009, Developmental cell.
[23] W. Min,et al. Mechanisms of endothelial dysfunction, injury, and death. , 2009, Annual review of pathology.
[24] W. Min,et al. AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice. , 2008, The Journal of clinical investigation.
[25] Xia Zhang,et al. The Isolation and Characterization of Murine Macrophages , 2008, Current protocols in immunology.
[26] W. Min,et al. AIP1 Is Critical in Transducing IRE1-mediated Endoplasmic Reticulum Stress Response* , 2008, Journal of Biological Chemistry.
[27] N. Van Rooijen,et al. Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice. , 2007, Cancer research.
[28] H. Aburatani,et al. ASK1-dependent recruitment and activation of macrophages induce hair growth in skin wounds , 2007, The Journal of cell biology.
[29] R. Agarwal,et al. Mechanisms of transcoelomic metastasis in ovarian cancer. , 2006, The Lancet. Oncology.
[30] M. David,et al. Cutting Edge: Apoptosis-Regulating Signal Kinase 1 Is Required for Reactive Oxygen Species-Mediated Activation of IFN Regulatory Factor 3 by Lipopolysaccharide1 , 2006, The Journal of Immunology.
[31] S. Gordon,et al. Ovarian Cancer Cells Polarize Macrophages Toward A Tumor-Associated Phenotype1 , 2006, The Journal of Immunology.
[32] W. Min,et al. SOCS1 Inhibits Tumor Necrosis Factor-induced Activation of ASK1-JNK Inflammatory Signaling by Mediating ASK1 Degradation* , 2006, Journal of Biological Chemistry.
[33] R. Freedman,et al. Defective Antitumor Function of Monocyte-Derived Macrophages from Epithelial Ovarian Cancer Patients , 2006, Clinical Cancer Research.
[34] John Condeelis,et al. Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis , 2006, Cell.
[35] W. Min,et al. Hsp90–Akt phosphorylates ASK1 and inhibits ASK1-mediated apoptosis , 2005, Oncogene.
[36] Kunihiro Matsumoto,et al. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity , 2005, Nature Immunology.
[37] G. Trinchieri,et al. Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. , 2005, Cancer research.
[38] W. Min,et al. Thioredoxin Promotes ASK1 Ubiquitination and Degradation to Inhibit ASK1-Mediated Apoptosis in a Redox Activity-Independent Manner , 2002, Circulation research.
[39] Jing Chen,et al. Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK–ERK independent mechanism , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[40] W. Min,et al. Laminar flow inhibits TNF-induced ASK1 activation by preventing dissociation of ASK1 from its inhibitor 14-3-3. , 2001, The Journal of clinical investigation.
[41] T Takahashi,et al. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis , 2001, EMBO reports.
[42] Xuan Sun,et al. Akt Phosphorylates and Negatively Regulates Apoptosis Signal-Regulating Kinase 1 , 2001, Molecular and Cellular Biology.
[43] D. Hilton,et al. SOCS: physiological suppressors of cytokine signaling. , 2000, Journal of cell science.
[44] Thomas N. Sato,et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. , 1999, Science.
[45] P. Schwartzberg,et al. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. , 1999, Molecular cell.
[46] D. Henley,et al. Microtubule Dysfunction Induced by Paclitaxel Initiates Apoptosis through Both c-Jun N-terminal Kinase (JNK)-dependent and -Independent Pathways in Ovarian Cancer Cells* , 1999, The Journal of Biological Chemistry.
[47] Minoru Takagi,et al. Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways , 1997, Science.
[48] A. A. Miles,et al. Vascular reactions to histamine, histamine‐liberator and leukotaxine in the skin of guinea‐pigs , 1952, The Journal of physiology.
[49] E. Lengyel,et al. Expression of the homeobox gene HOXA9 in ovarian cancer induces peritoneal macrophages to acquire an M2 tumor-promoting phenotype. , 2014, The American journal of pathology.
[50] A. Jemal,et al. Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.
[51] L. Tanoue. Cancer Statistics, 2009 , 2010 .
[52] A. Bikfalvi,et al. Tumor angiogenesis , 2020, Advances in cancer research.
[53] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.